发明名称 |
Methods for alleviating deleterious effects of 3-deoxyglucosone |
摘要 |
Disclosed is a class of compounds which inhibit the enzymatic conversion of fructose-lysine into fructose-lysine-3-phosphate in an ATP dependent reaction in a recently discovered metabolic pathway. According to the normal functioning of this pathway, fructose-lysine-3-phosphate (FL3P) is broken down to form free lysine, inorganic phosphate and 3-deoxyglucosone (3DG), the latter being a reactive protein modifying agent. 3DG can be detoxified by reduction to 3-deoxyfructose (3DF), or it can react with endogenous proteins to form advanced glycation end-product modified proteins (AGE-proteins). Also disclosed are therapeutic methods of using such inhibitors to alleviate deleterious effects of 3-deoxyglucosone (3DG).
|
申请公布号 |
US2006241023(A1) |
申请公布日期 |
2006.10.26 |
申请号 |
US20050322541 |
申请日期 |
2005.12.30 |
申请人 |
BROWN TRUMAN R;KEPPLER FRANCIS |
发明人 |
BROWN TRUMAN R.;KEPPLER FRANCIS |
分类号 |
A61K38/14;A61K31/00;A61K31/13;A61K31/197;A61K31/198;A61K31/275;A61K31/5375;A61K31/7008;C07H19/20;G01N33/66 |
主分类号 |
A61K38/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|